GSK221149A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK221149A, covering 2012-03-19 to 2017-12-13. Get the full timeline:
Most recent: Clinical Trial Update: The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor [Phase 2]